

Needs by area
Choose your area of concern
Cheekbones
Effects of ageing
Descent of cheek fat pads and loss of volume as a result of gravity3,5,12
Specific concern
Visible creases between sinking fat pads,2 giving a sad, bitter and tired look6
Expectations from aesthetic treatment
Adding of definition and sculpting for a younger-looking, more beautiful appearance2,3,6
No unsightly bloating (chipmunk look) of the face6
Natural plumping and lifting effect6
Long-lasting results7 with minimum side effects7,8
Treatment
TEOSYAL® PURESENSE ULTRA DEEP9
Cheeks
Effects of ageing
Loss of underlying fat, redistribution of fat3,12
Specific concern
Hollowing, creases and depressions creating a worn-out look2,6
Expectations from aesthetic treatment
Plumping out of hollowed area and rejuvenating the appearance2,3
Preserved facial dynamism6
Natural lifting effect & long-lasting results7 with minimum side effects7,8
Treatment
TEOSYAL RHA® 411
Nasolabial folds
Effects of ageing
Loss of underlying fat, skin elasticity and repeated muscle movements2,4,6
Specific concern
Asymmetries, deeper folds and sagging skin, giving a sad and tired look2,6
Expectations from aesthetic treatment
Removal of asymmetries and tightening of skin, filling in of pronounced creases2
Preserved facial dynamism (no frozen grin)6
Natural-looking rejuvenation6,7
Long-lasting results7 with minimum side effects7,8
Treatment
TEOSYAL RHA® 310
TEOSYAL RHA® 3, TEOSYAL RHA® 4 and TEOSYAL® PURESENSE ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend not use lidocaine-containing products and please refer to products without lidocaine. TEOSYAL® PURESENSE Ultra Deep exist also without lidocaine : TEOSYAL® ULTRA DEEP. They are class III medical device and are regulated health product bearing the CE marking (CE2797) under this regulation.
Local manifestations: inflammatory reactions (erythema, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (possibly granulomas).
General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant.
Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke.
Please consult your physician or pharmacist for more information.
Please refer to instructions for use. The product availability depends on registration, please contact your local distributor. Please inform the manufacturer TEOXANE of any side effects or any claim as soon as possible to the following address: medical@teoxane.com.